Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use during the high-risk college transition period. Digital tools like this are being evaluated because they can reach large numbers of students efficiently and adapt to individual needs. Results from this trial provide evidence on whether app-based support can meaningfully improve real-world mental health and substance use outcomes in this population.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides rigorous evidence on whether a scalable digital intervention can effectively address the convergence of mental health and substance use disorders in a high-risk population during a critical developmental period. The findings directly inform whether mobile app-based interventions can serve as feasible, cost-effective adjuncts to traditional clinical care in university settings where mental health resources are often limited. Demonstrating efficacy would support the integration of student-codeveloped digital tools into campus mental health infrastructure and potentially establish a replicable model for other institutions facing similar demand-capacity gaps.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 While the Minder app shows promise as a scalable digital intervention for the high-risk university population, clinicians should recognize several important limitations before endorsing it broadly. The study design and outcomes metrics are not fully detailed in this abstract, making it difficult to assess whether improvements in mental health and substance use represent clinically meaningful changes or merely statistical significance, and the lack of information about control conditions and follow-up duration limits our ability to determine durability of any benefits. Co-development with students is a genuine strength that may enhance engagement and relevance, yet digital interventions often struggle with real-world adherence and may inadvertently select for more motivated or digitally-native users, potentially limiting generalizability to students with the most severe symptoms. In clinical practice, the Minder app may serve as a useful adjunct for motivated university students seeking accessible mental health support or substance use monitoring, though it should not replace traditional screening, counseling, or treatment referral pathways, particularly for those with moderate to severe psychiatric or addiction disorders.